Adage Capital Partners
RPTP

Adage Capital Partners’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Adage Capital Partners’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-100,000
Closed -$1.58M – 815
2015
Q2 		$1.58M Buy
+100,000
New +$1.21M ﹤0.01% 690
2013
Q4 		– Sell
-1,000,000
Closed -$14.9M – 777
2013
Q3 		$14.9M Sell
1,000,000
-100,000
-9% -$1.2M 0.04% 431
2013
Q2 		$10.3M Buy
+1,100,000
New +$7.45M 0.03% 497

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Adage Capital Partners's RPTP Position: Q3 2015 in Review

Adage Capital Partners sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2015, closing a stake of 100,000 shares — an estimated $1.58M sold.

Adage Capital Partners first reported a position in RPTP in Q2 2013 and held it in 3 quarters. The position peaked at $14.9M in Q3 2013. 106 funds tracked by Wall St. Rank hold RPTP as of Q3 2015.

  • Adage Capital Partners reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2015 after selling out during the quarter.
  • Adage Capital Partners sold 100,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2015, an estimated $1.58M.
  • Adage Capital Partners first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 3 quarters.
  • Adage Capital Partners's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $14.9M in Q3 2013.
  • 106 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2015.

Based on Adage Capital Partners's 13F filing for Q3 2015, filed 16 Nov 2015.